Goldman Sachs’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Goldman Sachs’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,867	Closed	-$15K	–	6386
2022 Q3	$15K	Hold	1,867	–	–	﹤0.01%	5989
2022 Q2	$40K	Buy	+1,867	New	+$58.9K	﹤0.01%	6072

Other funds holding GMVD

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Goldman Sachs's GMVD Position: Q4 2022 in Review

Goldman Sachs sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q4 2022, closing a stake of 1,867 shares — an estimated $15K sold.

Goldman Sachs first reported a position in GMVD in Q2 2022 and held it in 2 quarters. The position peaked at $40K in Q2 2022. 6 funds tracked by Wall St. Rank hold GMVD as of Q4 2022.

Goldman Sachs reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 1,867 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q4 2022, an estimated $15K.
Goldman Sachs first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2022 and held it in 2 quarters.
Goldman Sachs's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $40K in Q2 2022.
6 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.